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Ataxia-telangiectasia-like disorder (ATLD) is a rare autosomal
recessive disorder, and has symptoms similar to ataxia-telangi-
ectasia (AT). ATLD is caused by mutations in the MRE11 gene,
involved inDNAdouble-strandbreak repair (DSBR). In contrast
to AT, ATLD patients lack key clinical features, such as telangi-
ectasia or immunodeficiency, and are therefore difficult to be
diagnosed. We report a female ATLD patient presenting with
hypergonadotropic hypogonadism and hypersegmented neutro-
phils, previously undescribed features in this disorder, and
potential diagnostic clues to differentiate ATLD from other
conditions. The patient showed slowly progressive cerebellar
ataxia from 2 years of age, and MRI revealed atrophy of the
cerebellum, oculomotor apraxia, mild cognitive impairment,
writing dystonia, hypergonadotropic hypogonadism with pri-
mary amenorrhea, and hypersegmented neutrophils. Western
blot assay demonstrated total loss of MRE11 and reduction of
ATM-dependent phosphorylation; thus, we diagnosed ATLD.
Genetically, a novelmissensemutation (c.140C>T)was detected
in the MRE11 gene, but no other mutation was found in the
patient. Our presenting patient suggests that impaired DSBR
may be associated with hypergonadotropic hypogonadism and
neutrophil hypersegmentation. In conclusion, when assessing
patients with ataxia of unknown cause, ATLD should be consid-
ered, and the gonadal state and peripheral blood smear samples
evaluated.  2014 Wiley Periodicals, Inc.
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INTRODUCTION
Ataxia-telangiectasia-like disorder (ATLD) is a very rare disease
with autosomal recessive inheritance, first reported as amilder form
of ataxia-telangiectasia (AT) [Hernandez et al., 1993]. Advances in
genetics have revealed that ATLD is caused by mutations in the
MRE11 gene, which is involved in DNA double-strand break
repair (DSBR) together with ATM, the causative gene in AT
[Savitsky et al., 1995; Stewart et al., 1999]. Patients with ATLD
show progressive cerebellar ataxia, abnormal eye movement, and
increased cellular radiosensitivity, all of which are also observed
in AT. However, in contrast to AT, ATLD patients exhibit no
extraneurological features, such as telangiectasia, reduced immu-
noglobulin levels, or raised alpha fetoprotein. The lack of such key
clinical featuresmakes it difficult to distinguish this condition from
other cerebellar ataxias; hence correct diagnosis is delayed in the
majority of cases.
Here, we report an ATLD patient presenting with previously
undescribed features; hypergonadotropic hypogonadism and
hypersegmented neutrophils. Both of these symptoms have poten-
tial as diagnostic clues in differentiating ATLD from other cerebel-
lar ataxias of unknown causes.
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CLINICAL REPORT
The patient was born to non-consanguineous, healthy, Japanese
parents after an uneventful gestation and delivery, and had no
history of perinatal or postnatal infections. Her elder brother was
healthy and there was no family history of neurological disease or
malignancy.
The patient’s development was normal during infancy; she was
able to sit without support at age 8 months and walked alone at
14 months. Mild unstable gait was noticed at 2 years of age, but
cranial computed tomography demonstrated no apparent abnor-
mality. She was then diagnosed with ataxic cerebral palsy and
observed periodically. Thereafter, her ataxic symptoms progressed
slowly and cranial magnetic resonance imaging (MRI) at 9 years of
age revealed mild cerebellar atrophy. As progression of cerebellar
atrophy was noted on MRI at 12 years, she was referred to our
hospital for further investigation.
The patient weighed 31 kg (2.5 standard deviation [SD]
scores), measured 150.4 cm (1.2 SD) in height, and had a head
circumference of 53 cm (1.0 SD) at the first visit to our hospital.
She had neither dysmorphic features nor skin lesions, including
telangiectasia. Neurological examination demonstrated cerebellar
ataxia: slurred speech, dysdiadokokinesis, and unsteady gait with a
tendency to fall. Finger-to-nose test revealed dysmetria and inten-
tion tremor on both sides. She also showed oculomotor apraxia.
Her IQ score was assessed with the Wechsler Intelligence Scale for
Children III: full scale, 60; verbal, 76; performance, 50. CranialMRI
revealed remarkable cerebellar atrophy (Fig. 1). Serum alpha
fetoprotein (AFP) and immunoglobulin (Ig) levels were within
the reference range: AFP, 2.0 ng/mL; Ig A, 181.5mg/dL; Ig G,
983.0mg/dL; and Ig M, 152.8mg/dL. Peripheral blood smears
showed neutrophils with hypersegmented and dysmorphic nuclei,
accounting for 1–3% of total white blood cells (Fig. 2). Her bone
marrow smear revealed hypocellular marrow without any signs of
malignancy (nucleated cell count, 11,500/ml;megakaryocytes, 3/ml;
M/E ratio, 2.5). Abnormal nuclear segmentation was only observed
in mature neutrophils. Fundoscopy, nerve conduction study, elec-
tromyography, and auditory brainstem response were all normal.
Endocrinologically, the patient had almost no secondary sexual
characteristics at 12 years of age. According to Tanner’s stages, her
breasts were stage 2 and her pubic hair stage 1. Laboratory tests
showed hypergonadotropic hypogonadism: follicle-stimulating
hormone, 114.9 IU/L (normal range for females at 11–14 years,
<0.1–12.0); luteinizing hormone, 36.4 IU/L (normal <0.1–13.4);
estradiol, 8.5 pg/ml (normal <20–87) [Soldin et al., 2005]. Her
ovaries were undetectable by abdominal MRI.
Subsequently, her ataxic symptoms progressed further and at
14 years of age she required a wheelchair. She also developed
difficulty in writing due to dystonic involuntary movements of
the right hand. She is presently 21-years-old and has been receiving
hormone replacement therapy for primary amenorrhea. There has
been no evidence of malignancies to date.
GENETIC ANALYSIS
Direct sequencing of all exons of theMRE11 gene revealed a novel
missensemutation (c.140C>T, p.Ala47Val) in exon 3 in the patient
and her father (Fig. 3A). No other mutations were found in either
the patient or her parents. However, sequencing analysis of mRNA
of MRE11 revealed a single peak for T, indicating that MRE11
mRNAwas expressedonly from themutant alleleT in thepatient, as
opposed to the double peaks for alleles C and T observed in the
father’s sample (Fig. 3B).Thismutationwasnot found in anypublic
variant database such as dbSNP (https://www.ncbi.nlm.nih.gov/
SNP/) and JSNP (http://snp.ims.u-tokyo.ac.jp/). We also per-
formed comparative genomic hybridization (CGH) to examine
small deletions or duplication. The CGHþ SNP 180K array (Agi-
lentTechnologies, SantaClara, CA)data indicated that therewasno
significant signal change detected within and proximal to the
MRE11 gene.
FIG. 1. Cranial MRI at age 15 years showing remarkable
cerebellar atrophy: (A) axial T1 weighted image; (B) sagittal T1
weighted image.
FIG. 2. Peripheral blood smears showing neutrophils with hyper-
segmented and dysmorphic nuclei.
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Western Blot ASSAY
Skin fibroblasts were obtained from the patient and from a healthy
donor control. The cells were irradiated with 5 Gy of gamma rays,
and then whole cell extracts were analyzed by western blot assay to
determine MRE11, RAD50, and NBS1 levels. In addition, we
assayed for irradiation-stimulating phosphorylation of ATM
(pATM), SMC1 (pSMC1), and p53 at serine 15 (p53-pS15), all
of which are involved in the signaling pathway initiated by activa-
tionofATM,alsobywesternblotting. ExpressionofMRE11protein
was almost completely absent from fibroblasts derived from the
patient, both before and after irradiation (Fig. 3C). The patient
showed significantly reduced levels of NBS1 and RAD50 proteins,
which, together with MRE11, form the MRE11/RAD50/NBS1
(MRN) complex [Czornak et al., 2008]. Bands representing
pATM, pSMC1, and p53-pS15 were also markedly reduced in
the patient compared to the control. These results demonstrate
that absence of theMRE11 protein unstabilized theMRN complex,
leading to reduced activation of ATM and proteins downstream of
ATM, such as SMC1 and p53.
We also examined whether the restoration of ATM phosphory-
lation was rescued by introducing the wild-typeMRE11 gene into
the cells. In this experiment, we used SV40-transformedfibroblasts.
SV40 transformation increasesATMandMRNcomplex in cultured
fibroblasts; therefore, MRE11, which was not detected in the non-
transformed patient’s fibroblasts (Fig. 3C), was weakly detected by
western blotting assay. However, phosphorylation of ATM and
SMC after irradiation was markedly decreased, indicating that
MRE11 protein of the patient was non-functioning. Both ATM
and SMC phosphorylation was restored by introduction of wild-
type MRE11, indicating that other members of MRN complex
functioned normally (Fig. 3D).
DISCUSSION
Here, we report a female patient with the following clinical features:
progressive cerebellar ataxia, oculomotor apraxia, writing dystonia,
hypergonadotropic hypogonadism, andhypersegmentedneutrophils.
Genetic analysis identified amissensemutation, c.140C>T (p.
Ala47Val), in MRE11 both the patient and her father. The
FIG. 3. Genetic analysis of the patient and her parents. A: A novel missense mutation (c.140C>T) in exon 3 of the MRE11 gene was detected
in the patient and the father. B: The mRNA (cDNA) analysis showing the presence of only the mutated allele-T at c.140, reflecting the absence
of mRNA from the other allele in the patient, but the presence of both alleles in the father. C: Western blot assay of skin fibroblasts from the
patient and a healthy control donor with or without irradiation (5 Gy gamma ray) demonstrating complete absence of MRE11 protein in the
patient. There were reduced levels of NBS1 and RAD50. Phosphorylation of ATM (pATM), SMC1 (pSMC1), and p53 (p53-pS15) were remarkably
low in the patient, and did not increase sufficiently after irradiation. D: ATM phosphorylation pathway was rescued by introducing wild-type
MRE11 gene. In the SV40-transformed patient fibroblasts, MRE11 protein expression was remarkably reduced and the deficit of ATM
phosphorylation after irradiation was also prominent. The introduction of wild-type MRE11 gene restored the MRE11 protein levels and the
phosphorylation of both ATM (pATM) and SMC (pSMC), indicating that the other members of MRN complex functioned normally.
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mutation of the 47th alanine residue is highly likely to be
pathogenic as it is located within the important nuclease domain
and is highly conserved fromplants to humans [Park et al., 2011].
We could not detect any other mutations as far as we investigat-
ed; however, the patient’s mRNA was expressed only from the
mutated T-allele and, in contrast, the father’s mRNA was
expressed from both of the mutated T-allele and the other
wild-type C-allele. As ATLD is an autosomal recessive disorder,
the most plausible explanation is that the patient is a compound
heterozygote for MRE11 comprising the paternally derived
mutated allele-T and an unidentified mutation on the other
normal-looking C-allele bearing chromosome that might be
derived from her mother. Such an unidentified alteration may
include a promoter regionmutation, an epigenetic alteration, or
an intronic mutation. This hidden mutated allele of the patient
would not expressmRNA, thus, mRNA is expressed as if it comes
only from the mutated T-allele. We analyzed MRE11 protein
levels and mRNA expression in the patient and her parents, but
the results were inconclusive. A similar result was described in a
previous report [Stewart et al., 1999]. We speculate mRNA
expression is likely increased through a feedback mechanism,
and the presence of one normal allele is sufficient to maintain
normal protein levels, as observed in the father’s sample. West-
ern blot assay revealed an almost complete absence of MRE11
and reduced expression of associated proteins in the patient,
even after irradiation. Furthermore, the deficit in ATM phos-
phorylation pathway was rescued by introducing wild-type
MRE11 gene into the patient’s fibroblasts, indicating that the
lack of MRE11 was pathogenic in this case. Based on these data,
we diagnosed ATLD, which is caused by MRE11 deficiency.
The association between cerebellar ataxia and hypogonadism
has been described as Gordon–Holmes cerebellar ataxia for more
than 100 years [Holmes, 1908]. The classification Gordon–Holms
type cerebellar ataxia is used to describe individuals presenting
with either hypogonadotropic or hypergonadotropic hypogonad-
ism; however, these two conditions are completely different [Amor
et al., 2001; Seminara et al., 2002]. Hypogonadotropic hypogo-
nadism is much more frequent and is secondary to reduced
pituitary production of gonadotropins. By contrast, hypergona-
dotropic hypogonadism means primary dysfunction of the ovary
or testis.
Due to the rarity of ATLD, the gonadal status of patients has not
been well described. In the case of AT, some female patients have
been reported to show primary ovarian failure [Zadik et al., 1978].
In addition, Atm-deficient mice, models of AT, demonstrate pri-
mary gonadal failure, including significantly atrophied gonads,
decreased levels of testosterone in males or decreased estradiol in
females, and elevated levels of follicle-stimulating hormone
[Rasheed et al., 2006]. These data suggest that the hypogonadism
observed in AT patients is essentially a result of primary gonadal
failure; although accompanying secondary gonadal failure due to
pituitary dysfunction canmask primary gonadal failure. According
to a study of Atm-deficient mice, Atm is necessary for appropriate
meiotic DNA recombination, and the authors speculate that Atm is
involved in the repair ofDNAbreaks duringmeiotic recombination
[Barlow et al., 1998]. As ATM and MRE11 proteins are known to
interact, and both play critical roles in the DSBR pathway, ATLD
patientsmay present with hypergonadotropic hypogonadism, sim-
ilar to AT patients.
Hypersegmented neutrophils are also known to occur in several
conditions that affect DNA replication, such as vitamin B12 defi-
ciency, folate deficiency, or other DNA damaging conditions.
Similarly, hypersegmentation of neutrophils in our patient could
be the result of impaired DSBR, though the underlying mechanism
remains to be established.
Unlike AT, extraneurological symptoms are not usually de-
scribed in patients diagnosed with ATLD, and this can lead to
delays in reaching a correct diagnosis. Uchisaka et al. [2009]
recently reported that two brothers with ATLD developed lung
adenocarcinoma during childhood, indicating the importance of
early diagnosis and careful observation formalignancies in patients
with ATLD, as well as those with AT.
In this study, we describe hypergonadotropic hypogonadism
and hypersegmented neutrophils, which are features previously
unreported in ATLD. It suggests that impaired DSBR may be
associated with hypergonadotropic hypogonadism and neutrophil
hypersegmentation. Our conclusion is that clinicians should con-
sider the possibility ofATLDandotherDNArepair disorders, when
assessing patients presenting with ataxia of unknown cause, and
evaluate the gonadal state and peripheral blood smear samples of
patients.
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